When we started Comprehend Systems in 2010, it was with patients top of mind. Our goal has always been to help pharmaceutical companies get new medical treatments to market faster, in order to improve—and save—more lives.
Related Articles
Many people on our team over the years have related to this on a very personal level. Many of us have had friends and loved ones who could have benefited from drugs and devices if they had only come out sooner. It’s probably safe to say that this issue affects all of us at some point in our lives.
In that spirit, Comprehend has signed a definitive agreement to be acquired by Saama Technologies, Inc. Our capabilities complement and reinforce Saama’s position as an advanced clinical data analytics innovator, and we are excited to become part of the Saama family.
Together, Comprehend and Saama will form the world’s preeminent clinical analytics platform company. By leveraging our unique strengths, we believe we can do an even better job of improving human health through the application of AI-powered clinical development solutions and software.
Our vision is the creation of a combined ecosystem of powerful, state-of-the-art solutions that leverage the latest advances in data science to fulfill unmet patient needs. We are dedicated to patients first and foremost and will continue to push the envelope when it comes to Clinical Trial Performance and risk mitigation.
The post Comprehend Joins Forces with Saama to Improve Clinical Trial Performance and Accelerate Treatments appeared first on Saama.
